Use of Sahadevi In Urinary Tract Infection

Open Labelled Single Arm Clinical Study to Evaluate The Efficacy Of Sahadevi In The Management of Mutrakriccha With Special Reference to Urinary Tract Infection

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032243

Enrollment

Registered

2021-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Sahadevi Choorna: Sahadevi Choorna 3gm before food with luke warm water Thrice in a Day for 15 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with Mutrakriccha. 2. Any of two or more symptoms described in the context of Mutrakriccha. 3. Patients irrespective of gender, caste and religion.

Exclusion criteria

Exclusion criteria: 1.Below the 20 years or above 70 years. 2.Heamaturia. 3.Renal failure 4.Pylonephritis 5.Nephrotic syndrome 6.Septicemia 7.Pregnant and lactating women 8.Chronic systemic illness uncontrolled DM and HTN, HIV, Malignancy, HBsAg, TB

Design outcomes

Primary

Measure	Time frame
Urinary Tract Infection will be treatedTimepoint: Urinary Tract Infection will be treated, follow up will be on 15th days and 30th days	—

Secondary

Measure	Time frame
Drug may Act also immunity against pathogens responsible for UTITimepoint: 30 Days	—

Countries

India

Contacts

Public ContactDr Hemant Toshikhane

Parul Institute of Ayurved

drhemantt@gmail.com8469496525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026